All In Biotech

Drug Trial Radar · NCT01535469

Operational Research for Cryptococcal Antigen Screening

Operational Research for Cryptococcal Antigen Screening to Improve ART Survival

Last checked: Nov 19, 2026Latest source record: Jun 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

3,049

Actual

Start

Jul 1, 2012

Primary completion

Jun 2015

Study completion Jun 2015

Sponsor

Lead sponsor
University of MinnesotaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Infectious Diseases Institute, Uganda; Makerere University; Centers for Disease Control and Prevention
First posted
Feb 17, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 14 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This will be a stepped wedge randomized trial design to evaluate the implementation of cryptococcal antigen (CRAG) screening and preemptive anti-fungal therapy of HIV-infected persons entering antiretroviral therapy (ART) outpatient treatment in Uganda. Those who are ART eligible with a CD4≤100 cells/mcL will have a serum/plasma CRAG performed by lateral flow assay. Those who are CRAG-positive and asymptomatic will be treated with high dose fluconazole. After 6 months survival with retention-in-care will be compared between those who are CRAG+ and CRAG negative

Conditions

  • Cryptococcal Meningitis
  • Cryptococcus Neoformans
  • Cryptococcosis

Interventions

  • FluconazoleDrug

    Fluconazole 800mg orally daily for 2 weeks, then 400mg daily for 8 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Retention in careTime frame: 6-month

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Infectious Disease Institute, Makerere University

    Kampala, Uganda

  • Kampala Capital Council Authority Clinics

    Kampala, Uganda

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.